Tevogen Bio Inc.

NASDAQ: TVGN · Real-Time Price · USD
0.95
-0.03 (-3.06%)
At close: Aug 15, 2025, 3:59 PM
0.94
-0.51%
After-hours: Aug 15, 2025, 07:49 PM EDT

Tevogen Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-53.56M -8.84K -13.72M -4.62M
Interest Income
n/a n/a n/a n/a
Pretax Income
-13.73M -67.33K 4.41M -15.6M
Net Income
-13.73M -67.33K 4.41M -15.6M
Selling & General & Admin
22.53M 2.27M 953.08K 1.66M
Research & Development
31.03M 4.4M 5.77M 2.96M
Other Expenses
n/a n/a -7.38M n/a
Operating Expenses
53.56M 2.27M 953.08K 4.62M
Interest Expense
n/a 256.03K n/a 598.5K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-53.56M 8.84K 953.08K 4.62M
Income Tax Expense
n/a n/a -230.82K -9.78M
Shares Outstanding (Basic)
146.67M 165.42M 120M 47.93M
Shares Outstanding (Diluted)
146.67M 165.42M 120M 47.93M
EPS (Basic)
-0.09 -0.00 0.04 -0.33
EPS (Diluted)
-0.09 -0.00 0.04 -0.33
EBITDA
-53.56M -2.27M -953.08K -28.75K
EBIT
-13.91M -8.84K -13.72K -28.75K
Depreciation & Amortization
403.58K 197.55K 230.82K 9.38K